WNT6 and cholangiocarcinoma: Furthermore, both WNT6 and HOXA9 are co-expressed in GBM and other diseases including leukemia, testicular germ cell tumor, melanoma, and cholangiocarcinoma (Goncalves et al., 2020), indicating that the scope of WNT6 function is broader.